The latest news and events from ECRIN and its partners

ECRIN hosted the e-workshop “Statistical environment for in-silico trials”

16 December 2021
ECRIN hosted on the 6th of December the e-workshop “Statistical environment for in-silico trials”. The workshop was organised as part of the H2020 SIMCor project and was attended by 50 participants, from the major EU-funded in-silico projects currently running (SIMCor, In Silico World, SimInSitu, SimCardioTest).

EULAC Permed Newsletter

8 December 2021

The EULAC PerMed December newsletter is now out. In this edition you will find information on upcoming webinars, the ERA PerMed: Joint Transnational Call 2022 on Prevention in Personalised Medicine, and the ICPerMed Best Practice in Personalised Medicine Recognition 2021.

European Commission (EC) opens funding call on development of new effective therapies for rare diseases

15 November 2021

On October 6th, 2021, the European Commission (EC) opened a new funding call titled “Tackling diseases (Two Stage – 2022) (HORIZON-HLTH-2022-DISEASE-06-two-stage)” in the context of the Horizon Europe Framework Programme on the development of new effective therapies for rare diseases.

EU-AMRI new alliance for BBMRI EATRIS and ECRIN

6 October 2021
EU-AMRI, the European Alliance of Medical Research Infrastructures, is the new alliance between the European medical research Infrastructures BBMRI, EATRIS and ECRIN. EU-AMRI aims to facilitate the effective and efficient use of scientific services, expertise and tools by academia and industry for the seamless translation of their scientific discoveries into new treatments and solutions for patients.